News

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose ...
That medication has been available by prescription since 2019 for the treatment of Type 2 diabetes but is not FDA-approved for weight loss. GLP-1 pills can be a promising option for people with ...
Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...